SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GuinnessGuy who wrote (72)2/3/1997 10:39:00 PM
From: Donald Gravenor   of 1321
 
Right, about the sight thing, I guess.
Concerning cancer treatment, the 3 biggies in North America are lung, breast, and colon (and prostate, I suppose). I don't think that photofrin is of any value in any of these diseases. Esophagus is rare, and usually invasive once it is diagnosed. I suppose that basal cell cancer is one area which has promise, particularly with lesions on the nose, ear, eyelid, and so forth. Who knows.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News